Mayer, Sebastian A.

Publications

Sort by

Co-Author Network

selected publications

Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD). Bone marrow transplantation. 2023 Letter GET IT
Screening Chest CT Prior to Allogenic Hematopoietic Stem Cell Transplantation. Transplantation and cellular therapy. 2023 Academic Article GET IT
Pre-Hematopoietic Stem Cell Transplantation Rituximab for Epstein-Barr Virus and Post-Lymphoproliferative Disorder Prophylaxis in Alemtuzumab Recipients. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 2
Reply to Caldwell et al. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2022 Academic Article GET IT
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma. Blood advances. 2022 Academic Article GET IT
Predictors of Covid-19 Vaccination Response After In-Vivo T-Cell-Depleted Stem Cell Transplantation. Transplantation and cellular therapy. 2022 Academic Article GET IT
Times cited: 4
C5b-9 and MASP2 deposition in skin and bone marrow microvasculature characterize hematopoietic stem cell transplant-associated thrombotic microangiopathy. Bone marrow transplantation. 2022 Letter GET IT
Times cited: 3
Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes. Leukemia & lymphoma. 2021 Academic Article GET IT
Times cited: 1
Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2021 Academic Article GET IT
Times cited: 15
Sequential intensive chemotherapy followed by autologous or allogeneic transplantation for refractory lymphoma. Leukemia & lymphoma. 2021 Academic Article GET IT
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response. Blood advances. 2020 Academic Article GET IT
Times cited: 4
Clinical Screening for COVID-19 in Asymptomatic Patients With Cancer. JAMA network open. 2020 Academic Article GET IT
Times cited: 19
Hematology and oncology clinical care during the coronavirus disease 2019 pandemic. CA: a cancer journal for clinicians. 2020 Academic Article GET IT
Times cited: 12
Poor graft function after T cell-depleted allogeneic hematopoietic stem cell transplant. Leukemia & lymphoma. 2020 Academic Article GET IT
Times cited: 6
Impact of alemtuzumab dosing and low-dose total body irradiation on cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation. Leukemia & lymphoma. 2020 Letter GET IT
Times cited: 2
Cord blood transplants supported by unrelated donor CD34⁺ progenitor cells. Bone marrow transplantation. 2020 Academic Article GET IT
Times cited: 3
Outcomes of Allogeneic Stem Cell Transplant for Elderly Patients with Hematologic Malignancies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2019 Academic Article GET IT
Times cited: 9
Haploidentical vs haplo-cord transplant in adults under 60 years receiving fludarabine and melphalan conditioning. Blood advances. 2019 Academic Article GET IT
Times cited: 23
High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma. Bone marrow transplantation. 2019 Academic Article GET IT
Times cited: 17
Prophylactic rituximab prevents EBV PTLD in haplo-cord transplant recipients at high risk. Leukemia & lymphoma. 2019 Academic Article GET IT
Times cited: 23
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 3
Bortezomib and Immune Globulin Have Limited Effects on Donor-Specific HLA Antibodies in Haploidentical Cord Blood Stem Cell Transplantation: Detrimental Effect of Persistent Haploidentical Donor-Specific HLA Antibodies. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2018 Academic Article GET IT
Times cited: 11
Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802. Blood advances. 2018 Academic Article GET IT
Times cited: 19
Reduced-Intensity Allogeneic Transplant for Acute Myeloid Leukemia and Myelodysplastic Syndrome Using Combined CD34-Selected Haploidentical Graft and a Single Umbilical Cord Unit Compared with Matched Unrelated Donor Stem Cells in Older Adults. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 16
Combined Haploidentical and Umbilical Cord Blood Allogeneic Stem Cell Transplantation for High-Risk Lymphoma and Chronic Lymphoblastic Leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 23
Granulocyte Colony-Stimulating Factor Use after Autologous Peripheral Blood Stem Cell Transplantation: Comparison of Two Practices. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 12
A Phase I Trial of High-Dose Lenalidomide and Melphalan as Conditioning for Autologous Stem Cell Transplantation in Relapsed or Refractory Multiple Myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2017 Academic Article GET IT
Times cited: 8
The Addition of Low-Dose Total Body Irradiation to Fludarabine and Melphalan Conditioning in Haplocord Transplantation for High-Risk Hematological Malignancies. Transplantation. 2017 Academic Article GET IT
Times cited: 12
Second allogeneic transplantation: ever? never? or sometimes. Leukemia & lymphoma. 2016 Comment GET IT
Times cited: 1
Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant. Annals of the American Thoracic Society. 2016 Academic Article GET IT
Times cited: 58
Haplo-cord transplant: HLA-matching determines graft dominance. Leukemia & lymphoma. 2016 Letter GET IT
Times cited: 7
Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors. Blood. 2016 Academic Article GET IT
Times cited: 33
Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 17
Cord blood chimerism and relapse after haplo-cord transplantation. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 16
Gastrin-releasing Peptide Receptor Imaging in Breast Cancer Using the Receptor Antagonist (68)Ga-RM2 And PET. Theranostics. 2016 Academic Article GET IT
Times cited: 69
Early human herpes virus type 6 reactivation in umbilical cord blood allogeneic stem cell transplantation. Leukemia & lymphoma. 2016 Academic Article GET IT
Times cited: 11
Frequency and Risk Factors Associated with Cord Graft Failure after Transplant with Single-Unit Umbilical Cord Cells Supplemented by Haploidentical Cells with Reduced-Intensity Conditioning. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2016 Academic Article GET IT
Times cited: 16
Allogeneic Transplantation for Patients With Advanced Myelofibrosis: Splenomegaly and High Serum LDH are Adverse Risk Factors for Successful Engraftment. Clinical lymphoma, myeloma & leukemia. 2016 Academic Article GET IT
Times cited: 12
Reduced intensity haplo plus single cord transplant compared to double cord transplant: improved engraftment and graft-versus-host disease-free, relapse-free survival. Haematologica. 2016 Academic Article GET IT
Times cited: 31
Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 93
Comparison of Subcutaneous versus Intravenous Alemtuzumab for Graft-versus-Host Disease Prophylaxis with Fludarabine/Melphalan-Based Conditioning in Matched Unrelated Donor Allogeneic Stem Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 12
Fluticasone, Azithromycin, and Montelukast Treatment for New-Onset Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Academic Article GET IT
Times cited: 119
A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 56
Human herpesvirus 6 infection in a bone marrow biopsy specimen after allogeneic stem cell transplantation. British journal of haematology. 2015 Academic Article GET IT
Times cited: 1
A strategy to reduce donor-specific HLA Abs before allogeneic transplantation. Bone marrow transplantation. 2014 Letter GET IT
Times cited: 17
A phase I study of CPX-351 in combination with busulfan and fludarabine conditioning and allogeneic stem cell transplantation in adult patients with refractory acute leukemia. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 14
A phase 1 study of bendamustine and melphalan conditioning for autologous stem cell transplantation in multiple myeloma. Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2013 Academic Article GET IT
Times cited: 30
Are low-intensity induction strategies better for older patients with acute myeloid leukemia?. Leukemia research. 2012 Academic Article GET IT
Times cited: 8
Phase 1 study of epigenetic priming with decitabine prior to standard induction chemotherapy for patients with AML. Blood. 2011 Academic Article GET IT
Times cited: 116
Thrombotic microangiopathy: differential diagnosis, pathophysiology and therapeutic strategies. The Mount Sinai journal of medicine, New York. 2005 Review GET IT
Times cited: 33
Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain. Molecular cell. 2003 Academic Article GET IT
Times cited: 223
Influence of drugs on myocardial iodine-123 metaiodobenzylguanidine uptake in rabbit myocardium. European journal of nuclear medicine. 2000 Academic Article GET IT
Times cited: 9

more ...

less ...

Background

education and training

M.D., University of Vienna Faculty of Medicine (Austria) 1998

Contact

full name

Sebastian A. Mayer

primary email

sam2033@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Sebastian A. Mayer Associate Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email

webpage